Life
Novartis CEO Takes Position on Anthropic’s Board
In recent biotech news, the CEO of Novartis has joined the board of Anthropic, alongside updates on Revolution Medicines' significant fundraising and Structure's potential acquisition moves.
editorial-staff
1 min read
Updated about 9 hours ago
Summary
The CEO of Novartis has recently been appointed to the board of Anthropic, a notable development in the biotech sector.
This news comes as Revolution Medicines has successfully raised $2 billion, marking a significant milestone for the company.
Additionally, Structure's latest hiring suggests possible efforts toward acquisitions, indicating a period of active growth and strategic maneuvering in the industry.
Updates
- No subsequent updates recorded.